CN106589135A - Targeting antibacterial peptide and preparation method and application thereof - Google Patents
Targeting antibacterial peptide and preparation method and application thereof Download PDFInfo
- Publication number
- CN106589135A CN106589135A CN201611052825.3A CN201611052825A CN106589135A CN 106589135 A CN106589135 A CN 106589135A CN 201611052825 A CN201611052825 A CN 201611052825A CN 106589135 A CN106589135 A CN 106589135A
- Authority
- CN
- China
- Prior art keywords
- ccf10
- peptide
- targeting
- antibacterial peptide
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention discloses a targeting antimicrobial peptide and a preparation method and application thereof. A sequence of the targeting antimicrobial peptide cCF10-C4 is shown in a sequence table SEQ ID No.1. The preparation method comprises the steps that enterococcus faecalis serves as a target bacterium to obtain the targeting antimicrobial peptide cCF10-C4 through design, a series of multi-structural-domain antimicrobial peptide molecules having selectivity to the enterococcus faecalis are established in a heterozygous mode. The design of a series of antimicrobial peptide molecules mainly includes two independent functional areas, namely a sterilization area and an identification area respectively. The targeting antimicrobial peptide has targeting selection capability to the target bacterium. The targeting antimicrobial peptide cCF10-C4 is conductive to reestablishment of microecological balance after treatment.
Description
Technical field
The invention belongs to biological technical field, and in particular to a kind of targeting antibacterial peptide and its preparation method and application.
Background technology
Antibacterial peptide is the small molecule polypeptide being present in organism natural immune defence system, participates in the immunity of body
Defense function, is that body resists first barrier that pathogenic microorganism is attacked.Antibacterial peptide is generally by 12-50 amino acid residue group
Into molecular weight is less than 10kDa, and its common feature is containing positively charged aminoacid and hydrophobic amino acid, with amphipathic
And cationic, there is killing or inhibiting effect to various bacteria, funguses, virus, parasite even cancerous cell.
But antibacterial peptide is identical with conventional antibiotic mostly to be extensive pedigree antibiotic, not only microorganism resistance mutation is produced
Great selection pressure.Importantly, extensive pedigree antibiotic kill pathogen while also kill it is beneficial just
Often flora, serious destruction is caused to microecological balance, cause the antibiotic such as clinically common secondary infection it is related and
Send out disease, result in the state of an illness further deteriorate, the serious negative consequences such as extended treatment cycle.Therefore, a class is especially needed at present
" intelligent " targeting antibacterials selective to pathogen, can be while pathogenic bacterium be killed, to microecological environment
Cause minimally to destroy, this is beneficial to rebuild microecological balance, and for body digital preservation is provided.
The content of the invention
Based on above weak point, it is an object of the invention to provide a kind of targeting antibacterial peptide cCF10-C4 and its preparation side
Method and application, the antibacterial peptide has targeting selective power to object bacteria.
The purpose of the present invention is realized by following technology:A kind of targeting antibacterial peptide cCF10-C4, its sequence such as sequence table SEQ
Shown in ID No.1.
The present invention also has following technical characteristic:
1st, a kind of preparation method of targeting antibacterial peptide cCF10-C4 is as follows:
(1) using broad spectrum antimicrobial peptide C6 as female peptide, from the pheromone that there is specific recognition to act on to enterococcus faecalis
CCF10 connects the two functional areas using GGG as connector as identification region, and design has been obtained to be had to object bacteria
Selective antibacterial peptide cCF10-C6;
(2) replace the K in the 16th, cCF10-C6 active center with negatively charged E to reduce net positive charge number, design is obtained
There is the targeting antibacterial peptide cCF10-C4 of specificity to object bacteria;
(3) cCF10-C4 peptide resins are obtained by Peptide synthesizer using solid-state chemical reaction method method, by the peptide resin for obtaining
After TFA cuttings, a polypeptide is obtained;
(4) after reversed-phase high-performance liquid chromatography purification and Mass Spectrometric Identification, that is, the preparation of polypeptide is completed.
2nd, a kind of targeting antibacterial peptide cCF10-C4 as described above, the application in targeting antibacterials are prepared.
The experimental technique of the antibacterial peptide prepared by this method is simple, and the antibacterial peptide to obtaining carries out antibacterial and hemolytic activity
Detection, find cCF10-C4 can specific killing enterococcus faecalis, to staphylococcus aureuses, staphylococcus epidermidiss, escherichia coli,
S. pullonum, Salmonella typhimurium do not have inhibitory action, show accurately targeting specific, and with very low
Hemolytic activity.In sum, cCF10-C4 is a kind of targeting antibacterial peptide with higher using value, that is, prove the method pair
In the accurate targeting antibacterial peptide effect is significant of design.
Description of the drawings
Fig. 1 is the hemolytic activity result figure of antibacterial peptide.
Specific embodiment
With reference to embodiment and accompanying drawing, the present invention is described in further detail, but embodiments of the present invention are not limited
In this.
Embodiment 1
Two methods of the present embodiment combining information element labelling technique and optimization positive changes be optimal to object bacteria
The effect of specificity, antibacterial peptide cCF10- is obtained using enterococcus faecalis (Enterococcus faecalis) as object bacteria design
C4, is constructed a series of to the selective Multidomain antibacterial peptide molecule of enterococcus faecalis by way of heterozygosis.The series
The MOLECULE DESIGN of antibacterial peptide mainly includes two independent functional areas, and respectively sterilize region and identification region.
The design of antibacterial peptide
Using broad spectrum antimicrobial peptide C6 as female peptide, from the pheromone cCF10 that there is specific recognition to act on to enterococcus faecalis
As identification region, the two functional areas are connected using GGG as connector, design has obtained having selectivity to object bacteria
Antibacterial peptide cCF10-C6, replace the K in the 16th, cCF10-C6 active center with negatively charged E on this basis reduce it is net just
Charge number, so as to further improve specificity of the targeting antibacterial peptide to object bacteria, design obtains having specificity to object bacteria
Targeting antibacterial peptide cCF10-C4.The aminoacid sequence of antibacterial peptide is as shown in table 1.
The aminoacid sequence of the antibacterial peptide of table 1
Embodiment 2
Solid-state chemical reaction method method composite signal element labelling antibacterial peptide
1st, the preparation of antibacterial peptide is carried out one by one from C-terminal to N-terminal, is completed by Peptide synthesizer.First by Fmoc-X (X
It is first aminoacid of C-terminal of each antibacterial peptide) Wang resins are linked into, then slough and X-Wang trees are obtained after Fmoc groups
Fat;Again by Fmoc-Y-Trt-OH (9- fluorenes methoxy carboxyl-trimethyl-Y, Y is second aminoacid of each antibacterial peptide C-terminal);According to
This program is synthesized to N-terminal from C-terminal successively, until synthesis is finished, the resin of the side chain protected for obtaining sloughing Fmoc groups;
2nd, in peptide resin obtained above, cutting reagent is added, under 20 DEG C of lucifuges 2h is reacted, filtered;Precipitation TFA (three
Fluoroethanoic acid) washing, washing liquid is mixed with above-mentioned filtrate, Rotary Evaporators concentration, the pre-cooling for adding 10 times or so volumes is anhydrous
Ether, -20 DEG C of precipitation 3h, separates out white powder thing, and 10min is centrifuged with 2500g, collects precipitation, then washs heavy with absolute ether
Form sediment, vacuum drying obtains polypeptide, wherein cutting reagent by TFA, water and TIS (tri isopropyl chlorosilane) according to mass ratio 95:
2.5:2.5 mix;
3rd, column equilibration 30min is carried out using 0.2mol/L sodium sulfate (phosphoric acid is adjusted to pH7.5), uses 90% acetonitrile solution
Dissolving polypeptide, filters, the anti-phase normal pressure posts of C18, and (eluant is methanol and aqueous sodium persulfate solution according to volume ratio to adopt gradient elution
For 30:70~70:30 mixing), flow velocity is 1mL/min, and detection ripple is 220nm, collects main peak, lyophilizing;Recycle anti-phase C18 posts
It is further purified, eluent A is 0.1%TFA/ aqueous solutions;Eluent B is 0.1%TFA/ acetonitrile solutions, and wash-out concentration is 25%
B~40%B, elution time is 12min, and flow velocity is 1mL/min, then ibid collects main peak, lyophilizing;
4th, the identification of antibacterial peptide:Antibacterial peptide obtained above is analyzed through electron spray mass spectrometry, the purity of antibacterial peptide is big
In 95%.
Embodiment 3
The measure of antibacterial peptide activity
1st, the measure of antibacterial activity:Antibacterial peptide is configured as into certain storing liquid in case using.Using micro broth dilution
Method determines the minimal inhibitory concentration of several antibacterial peptides.It is dilute using two times using 0.01% acetic acid (containing 0.2%BSA) as diluent
Interpretation of the law configures successively the antibacterial peptide solution of graded series.Take the μ L of above-mentioned solution 100 to be placed in 96 porocyte culture plates, then distinguish
Add isopyknic bacterium solution to be measured (~105Individual/mL) in each hole.It is respectively provided with positive control (not containing containing bacterium solution anti-
Bacterium peptide) and negative control (both without bacterium solution or without peptide).37 DEG C of constant temperature culture 20h, have no that bottom hole portion has muddy existing with naked eyes
The as minimal inhibitory concentration of elephant.As a result it is as shown in table 2.
The bacteriostatic activity of the antibacterial peptide of table 2
It can be seen from Table 2 that, pheromone cCF10 does not have bacteriostatic activity, and antibacterial peptide C6 has broad spectrum antibiotic activity, even
Meeting cCF10 can improve bacteriostatic activity of the antibacterial peptide to enterococcus faecalis (E.faecalis), and to the antibacterial work of other non-target bacterium
Property show substantially reduction;When positive changes are reduced to 4 (cCF10-C4), lose to the antibacterial of all non-targeted bacterial strains
Ability, but the bacteriostatic activity to E.faecalis does not have significant change, shows accurately targeting specific.
2nd, the measure of hemolytic activity:The fresh blood 1mL of collection people, during 2mLPBS solution is dissolved into after anticoagulant heparin,
1000g is centrifuged 5min, collects erythrocyte;Washed with PBS 3 times, then it is resuspended with 10mL PBS;Take 50 μ L red cell suspensions and 50 μ L
The antibacterial peptide solution mix homogeneously of the variable concentrations dissolved with PBS, the constant-temperature incubation 1h in 37 DEG C of incubators;Take out after l h, 4
DEG C, 1000g centrifugation 5min;Take out supernatant microplate reader light-metering absorption value at 570nm;Average per group, and compare point
Analysis.Wherein 50 μ L erythrocyte add 50 μ LPBS as negative control;50 μ L erythrocyte add 50 μ L0.1%Tritonx-100 as sun
Property control.Minimum hemolytic concentration is antibacterial peptide concentration when antibacterial peptide causes 10% hemolysis rate.As a result it is as shown in Figure 1.As figure can
To find out, the antibacterial peptide hemolytic activity compared with female peptide after link information element cCF10 is slightly improved, but cCF10-C4 is in maximum survey
The hemolysis rate for determining to cause under 256 μM of concentration is still below 15%, illustrates that the antibacterial peptide has relatively low cytotoxicity.
Result above shows, the targeting antibacterial peptide cCF10-C4 that present invention design is obtained can specific killing enterococcus faecalis,
To escherichia coli, staphylococcuses etc. without effect.Simultaneously relatively low cytotoxicity is shown, with developing into the anti-enterococcus faecalis of targeting
The potentiality of medicine.
The > Northeast Agricultural Universities of < 110
A kind of targeting antibacterial peptides of the > of < 120 and its preparation method and application
The > 1 of < 160
The > 1 of < 210
The > 24 of < 211
The > PRT of < 212
The > artificial sequences of < 213
The > 1 of < 400
Leu Val Thr Leu Val Phe Val Gly Gly Gly Trp Lys Trp Lys Trp Glu Asn Gly Lys Trp
1 5 10 15 20
Lys Trp Lys Trp-NH2
21 24
Claims (3)
1. a kind of targeting antibacterial peptide cCF10-C4, it is characterised in that its sequence is as shown in sequence table SEQ ID No.1.
2. a kind of preparation method of targeting antibacterial peptide cCF10-C4, it is characterised in that method is as follows:
(1) using broad spectrum antimicrobial peptide C6 as female peptide, made from the pheromone cCF10 that there is specific recognition to act on to enterococcus faecalis
For identification region, the two functional areas are connected using GGG as connector, design has obtained selective to object bacteria
Antibacterial peptide cCF10-C6;
(2) replace the K in the 16th, cCF10-C6 active center with negatively charged E to reduce net positive charge number, design is obtained to mesh
Mark bacterium has the targeting antibacterial peptide cCF10-C4 of specificity;
(3) cCF10-C4 peptide resins are obtained by Peptide synthesizer using solid-state chemical reaction method method, the peptide resin for obtaining is passed through
After TFA cuttings, a polypeptide is obtained, sequence is as shown in sequence table SEQ ID No.1;
(4) after reversed-phase high-performance liquid chromatography purification and Mass Spectrometric Identification, that is, the preparation of polypeptide is completed.
3. applications of a kind of targeting antibacterial peptide cCF10-C4 in targeting antibacterials are prepared according to claim 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611052825.3A CN106589135B (en) | 2016-11-25 | 2016-11-25 | A kind of targeting antibacterial peptide and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611052825.3A CN106589135B (en) | 2016-11-25 | 2016-11-25 | A kind of targeting antibacterial peptide and its preparation method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106589135A true CN106589135A (en) | 2017-04-26 |
CN106589135B CN106589135B (en) | 2018-08-28 |
Family
ID=58593326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611052825.3A Active CN106589135B (en) | 2016-11-25 | 2016-11-25 | A kind of targeting antibacterial peptide and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106589135B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109232717A (en) * | 2018-08-31 | 2019-01-18 | 东北农业大学 | One kind is for Gram-negative bacteria targeting antibacterial peptide and production method and application |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0301078B1 (en) * | 1987-02-06 | 1995-05-10 | Xoma Corporation | Polypeptides with activity against gram-positive and gram-negative bacteria |
WO1998040401A2 (en) * | 1997-03-10 | 1998-09-17 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
WO2001061029A2 (en) * | 2000-02-17 | 2001-08-23 | Zetatronics Limited | Identification method |
CN1532282A (en) * | 2003-03-19 | 2004-09-29 | 成都阳辉生物科技有限责任公司 | Novel antienterococci polypeptide and its preparing method |
CN1671737A (en) * | 2002-05-24 | 2005-09-21 | 应用超微***股份有限公司 | Export and modification of (poly)peptides in the lantibiotic way |
CN102827255A (en) * | 2012-08-09 | 2012-12-19 | 东北农业大学 | Antibacterial peptide GW13 and its preparation method and use |
CN104592360A (en) * | 2015-01-07 | 2015-05-06 | 中山大学 | Alkaline antibacterial peptide as well as targeting design and application thereof |
-
2016
- 2016-11-25 CN CN201611052825.3A patent/CN106589135B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0301078B1 (en) * | 1987-02-06 | 1995-05-10 | Xoma Corporation | Polypeptides with activity against gram-positive and gram-negative bacteria |
WO1998040401A2 (en) * | 1997-03-10 | 1998-09-17 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
WO2001061029A2 (en) * | 2000-02-17 | 2001-08-23 | Zetatronics Limited | Identification method |
GB2363842A (en) * | 2000-02-17 | 2002-01-09 | Zetatronics Ltd | Micro-organism identification |
CN1671737A (en) * | 2002-05-24 | 2005-09-21 | 应用超微***股份有限公司 | Export and modification of (poly)peptides in the lantibiotic way |
CN1532282A (en) * | 2003-03-19 | 2004-09-29 | 成都阳辉生物科技有限责任公司 | Novel antienterococci polypeptide and its preparing method |
CN102827255A (en) * | 2012-08-09 | 2012-12-19 | 东北农业大学 | Antibacterial peptide GW13 and its preparation method and use |
CN104592360A (en) * | 2015-01-07 | 2015-05-06 | 中山大学 | Alkaline antibacterial peptide as well as targeting design and application thereof |
Non-Patent Citations (3)
Title |
---|
ROBERT E.W.HANCOCK ET AL: "Cationic peptides:a new source of antibiotics", 《TIBTECH FEBRUARY》 * |
SHIN YONG PARK ET AL: "Extracellular Gelatinase of Enterococcus faecalis Destroys a Defens System in Insect Hemolymph and human Serum", 《INFECTION AND IMMUNITY》 * |
单安山: "抗菌肽的功能、研发与应用", 《中国农业科学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109232717A (en) * | 2018-08-31 | 2019-01-18 | 东北农业大学 | One kind is for Gram-negative bacteria targeting antibacterial peptide and production method and application |
CN109232717B (en) * | 2018-08-31 | 2021-08-20 | 东北农业大学 | Gram-negative bacterium targeted antibacterial peptide, and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN106589135B (en) | 2018-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108570103B (en) | One kind is rich in tryptophan antibacterial peptide WK12 and its preparation method and application | |
CN103923189B (en) | Derived peptide IR2 of one boar derived antimicrobial peptide and its preparation method and application | |
CN109232717B (en) | Gram-negative bacterium targeted antibacterial peptide, and preparation method and application thereof | |
CN107266533B (en) | A kind of α spirals antibacterial peptide RL and its preparation method and application | |
CN107746429A (en) | A kind of end symmetrical antibacterial peptide PP and its preparation method and application | |
CN106749532A (en) | Multiply β hair fasteners small peptide and preparation method and application with tolerance protein enzyme | |
CN111423501B (en) | Antibacterial peptide derived from scorpion venom as well as preparation method and application thereof | |
CN106749531A (en) | Tryptophan slide fastener β hair fastener antibacterial peptides and preparation method thereof and with application | |
CN109810178A (en) | A kind of resistance to enzymolysis antibacterial peptide I9H12 and its preparation method and application | |
CN107056893B (en) | A kind of antibacterial peptide RF3 of the anti-Candida albicans of resistance to amphotericin B and application | |
CN111533786A (en) | Beta-hairpin antibacterial peptide with tryptophan and arginine cross-chain interaction and preparation method thereof | |
CN112661832A (en) | High-stability antibacterial peptide and application thereof | |
CN104650208B (en) | Derived peptide of one breeder derived antimicrobial peptide and its preparation method and application | |
CN102827255B (en) | Antibacterial peptide GW13 and its preparation method and use | |
CN117924424B (en) | Beta-hairpin antibacterial peptide based on D-type amino acid cross-chain interaction, and preparation method and application thereof | |
CN113549137B (en) | Proline-rich antibacterial peptide Pyr-2 targeting gram-negative bacteria and preparation method and application thereof | |
CN112778401B (en) | Caprylic acid acylation modified antibacterial peptide and application thereof | |
CN102391362B (en) | Group of animal-derived cationic antibacterial peptides and its application | |
CN106366162B (en) | A kind of efficiently α spiral antibacterial peptides GV and its preparation method and application | |
CN111533781B (en) | Non-specific receptor binding type fungus targeted antibacterial peptide and preparation method and application thereof | |
CN110294809B (en) | Targeting staphylococcus aureus antibacterial peptide S2 and preparation method and application thereof | |
CN106589135B (en) | A kind of targeting antibacterial peptide and its preparation method and application | |
CN102382186B (en) | Antibacterial peptide GLI23 derived from linear chicken beta-phylaxin4 (RL38) and preparation method thereof | |
CN109705195B (en) | Escherichia coli targeted antibacterial peptide KI-QK and preparation method and application thereof | |
CN106432513B (en) | A kind of efficiently hybridization antibacterial peptide LI and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |